edetic acid has been researched along with motexafin gadolinium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashemy, SI; Holmgren, A; Ungerstedt, JS; Zahedi Avval, F | 1 |
1 other study(ies) available for edetic acid and motexafin gadolinium
Article | Year |
---|---|
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cytosol; Disulfides; Dose-Response Relationship, Drug; Edetic Acid; Electrons; Escherichia coli; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Insulin; Kinetics; Metalloporphyrins; Models, Chemical; NADP; Oxidation-Reduction; Oxidative Stress; Oxygen; Protein Binding; Rats; Reactive Oxygen Species; Ribonucleotide Reductases; Spectrophotometry; Thioredoxin-Disulfide Reductase; Thioredoxins; Time Factors | 2006 |